Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Domestic resignation

Marty Makary Resigns from FDA

Analysis based on 10 articles · First reported May 12, 2026 · Last updated May 13, 2026

Sentiment
0
Attention
4
Articles
10
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The resignation of Marty Makary from the United States — Food and Drug Administration and the appointment of Kyle Diamantas as acting commissioner could lead to shifts in regulatory policies concerning pharmaceuticals, particularly abortion pills like Mifepristone, and vaping products. This change in leadership may impact the stock prices of pharmaceutical and tobacco companies, depending on the new administration's stance on drug approvals and product regulations.

Pharmaceuticals Healthcare Tobacco

Dr. Marty Makary resigned as Commissioner of the United States — Food and Drug Administration on Tuesday, following widespread reports of his impending firing. President Donald Trump confirmed the resignation and appointed Kyle Diamantas as acting commissioner. Makary's departure was largely attributed to disagreements over his handling of the abortion pill Mifepristone, with pro-life advocates like Susan B. Anthony Pro-Life America and Senator Josh Hawley criticizing his policies. He also faced frustration from Donald Trump regarding his reluctance to approve flavored vaping products. Health and Human Services Secretary Robert F. Kennedy Jr. reportedly pushed for Makary's resignation. The event signals a potential shift in the United States — Food and Drug Administration's regulatory approach under new leadership.

100 Marty Makary resigned
80 Donald Trump confirmed resignation Marty Makary
60 Robert F. Kennedy Jr. pushed for resignation Marty Makary
40 Marty Makary blocked authorization
per
Marty Makary resigned as Commissioner of the United States — Food and Drug Administration amidst reports of being fired due to disagreements over abortion pill policy and flavored vaping products.
Importance 100 Sentiment -20
govactor
The United States — Food and Drug Administration is undergoing a leadership change with Marty Makary's resignation and Kyle Diamantas taking over as acting commissioner, potentially signaling shifts in regulatory policy.
Importance 90 Sentiment 0
per
Donald Trump confirmed Marty Makary's resignation and appointed Kyle Diamantas as acting commissioner, indicating his influence on the United States — Food and Drug Administration's leadership and policy direction.
Importance 80 Sentiment 0
per
Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.
Importance 70 Sentiment 10
ngo
Susan B. Anthony Pro-Life America had long called for Marty Makary's firing due to his handling of abortion pill policies, viewing his resignation as a positive development.
Importance 40 Sentiment 10
per
Josh Hawley, a strong advocate for safeguards on the abortion pill, celebrated Marty Makary's exit as an opportunity for the United States — Food and Drug Administration to reset its policies.
Importance 30 Sentiment 10
per
Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, expressed satisfaction with Marty Makary's departure, hoping for a new United States — Food and Drug Administration commissioner to end mail-order abortion drug regimes.
Importance 30 Sentiment 10
per
Dan Hawkins, president of Students for Life, expressed skepticism that Marty Makary's exit alone would spur change on the abortion pill issue, emphasizing Donald Trump's ultimate responsibility.
Importance 20 Sentiment 0
per
Robert F. Kennedy Jr., as Health and Human Services Secretary, pushed for Marty Makary's resignation, indicating his influence on the United States — Food and Drug Administration's leadership.
Importance 20 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.